NP-011

N/A

Report date: 2025/05/13 14:41:10

Base Information

Drug NameNP-011
Drug Alias NamerhMFG-E8NP-011
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionIntegrin alpha-V/beta-3 modulatorsIntegrin alpha-V/beta-5 modulators
TargetsIntegrin alpha-V/beta-3Integrin alpha-V/beta-5
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNexell Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNEXEL Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A